Operating and ordinary profit growth from an overall improvement in cost of sales
First written in FY2019. 4 of 8 entries say "Worsened", first in FY2023. Latest entry: 2026-07-31.
Yutaka Foods moved to the "Worse" side of this theme in 2022.
0 other companies' latest entry also says "Worsened".
- 2026-07-31WorsenedEarnings
「The food industry is also expected to face a continued challenging business environment as raw material costs remain high.」
The expectation that raw material costs will remain high was reconfirmed as a source of pressure on the earnings environment. - FY2026WorsenedAnnual report
「Cost of sales rose 8.3% year on year and selling, general and administrative expenses increased 0.2%. As a result, operating profit was ¥143 million, a decrease of ¥538 million, or 79.0%, from the same period of the previous year, while ordinary profit was ¥291 million, a decrease of ¥509 million, or 63.6%.」
Following increases in the cost of sales ratio through the previous fiscal year, the cost of sales rose 8.3% in the current fiscal year, resulting in substantial declines in operating and ordinary profit. - FY2024WorsenedAnnual report
「As the cost of sales ratio rose 2.3% year on year and the SG&A expense ratio to net sales fell 0.1%, operating profit decreased by ¥306 million, or 34.3%, to ¥586 million, while ordinary profit decreased by ¥312 million, or 30.9%, to ¥697 million.」
The increase in the cost of sales ratio was substantial, following the 2.4% increase in the previous fiscal year, and could not be offset by the modest decline in the SG&A expense ratio to net sales, resulting in declines in operating and ordinary profit. - FY2023WorsenedAnnual report
「As the cost of sales ratio rose 2.4% year on year and the SG&A expense ratio to net sales rose 0.2%, operating profit decreased by ¥465 million, or 34.3%, to ¥892 million, while ordinary profit decreased by ¥449 million, or 30.8%, to ¥1,010 million.」
Both the cost of sales ratio and the SG&A expense ratio to net sales rose, widening the declines in operating and ordinary profit. - FY2022ReframedAnnual report
「As the cost of sales ratio rose 0.3% year on year and the SG&A expense ratio to net sales fell 0.3%, operating profit decreased by ¥35 million, or 2.5%, to ¥1,358 million, while ordinary profit decreased by ¥21 million, or 1.5%, to ¥1,459 million.」
The explanation changed from profit growth driven by declines in the cost of sales and SG&A expense ratios in the previous fiscal year to a simultaneous mention of a higher cost of sales ratio and a lower SG&A expense ratio to net sales in the current fiscal year, with operating and ordinary profit declining. - FY2021AdvancedAnnual report
「In terms of earnings, operating profit increased by ¥378 million, or 37.3%, year on year to ¥1,393 million, while ordinary profit increased by ¥361 million, or 32.3%, to ¥1,481 million, as the cost of sales ratio fell 1.3% year on year and the SG&A expense ratio to net sales fell 0.3%.」
The company changed from profit declines caused by increases in the cost of sales and SG&A expense ratios in the previous fiscal year to operating and ordinary profit growth driven by declines in both ratios. - FY2020ReframedAnnual report
「As the cost of sales ratio rose 0.2% year on year and the SG&A expense ratio to net sales rose 0.2%, operating profit decreased by ¥146 million, or 12.6%, to ¥1,015 million, while ordinary profit decreased by ¥158 million, or 12.4%, to ¥1,119 million.」
The explanation changed from profit growth driven by an overall improvement in the cost of sales in the previous fiscal year to profit declines driven by increases in the cost of sales ratio and the SG&A expense ratio to net sales. - FY2019First statedAnnual report
「In terms of earnings, operating profit increased by ¥176 million, or 17.9%, year on year to ¥1,161 million, while ordinary profit increased by ¥188 million, or 17.3%, to ¥1,277 million, as a result of an overall improvement in the cost of sales.」
Although revenue declined, the company explained that the overall improvement in the cost of sales was a factor behind the increases in operating and ordinary profit.